chrX-66173699-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001367233.3(HEPH):c.523G>A(p.Asp175Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000579 in 1,208,138 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001367233.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEPH | NM_001367233.3 | c.523G>A | p.Asp175Asn | missense_variant | 4/21 | ENST00000343002.7 | NP_001354162.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEPH | ENST00000343002.7 | c.523G>A | p.Asp175Asn | missense_variant | 4/21 | 1 | NM_001367233.3 | ENSP00000343939.2 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111627Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33799
GnomAD3 exomes AF: 0.00000554 AC: 1AN: 180528Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65328
GnomAD4 exome AF: 0.00000456 AC: 5AN: 1096511Hom.: 0 Cov.: 30 AF XY: 0.00000276 AC XY: 1AN XY: 361985
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111627Hom.: 0 Cov.: 22 AF XY: 0.0000296 AC XY: 1AN XY: 33799
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2024 | The c.685G>A (p.D229N) alteration is located in exon 4 (coding exon 4) of the HEPH gene. This alteration results from a G to A substitution at nucleotide position 685, causing the aspartic acid (D) at amino acid position 229 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at